Galantamine Tablets
utilized for alzheimer's disease to alleviate cognitive decline.
Strengths: 4 · 8mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Reminyl
- Therapeutic class
Acetylcholinesterase Inhibitor
- Pharmacological class
Acetylcholinesterase Inhibitor
- Minor side effects
nausea; vomiting; dizziness
- Moderate side effects
weight loss; bradycardia; insomnia
- Serious side effects
atrioventricular block — requires immediate medical attention
- Dosage forms
Tablet
- Administration route
Oral use
- Patient summary
utilized for alzheimer's disease to alleviate cognitive decline.
- Prescription status
POM
- Manufacturer
Janssen-Cilag
- Onset Time
2–4 weeks
- Duration
long-term
- Storage instructions
Store in a cool, dry place away from light.
- Drug interactions
ketoconazole; paroxetine
- Age restrictions
Adult use.
- Pregnancy and breastfeeding
Consult doctor before use.
Contraindications
hypersensitivity to galantamine; severe hepatic impairment; severe renal impairment
Precautions and warnings
monitor for gastrointestinal symptoms; use with care in patients with bradycardia
Mechanism of action
A peripherally acting acetylcholinesterase inhibitor that also modulates nicotinic receptors. This improves cholinergic neurotransmission, effective for supporting cognitive function in early-to-moderate dementia.
Galantamine Tablets
utilized for alzheimer’s disease to alleviate cognitive decline.
Editorial Notes
- Active ingredient(s): Galantamine
- Listed indication(s): Alzheimer’s Disease
Usually available as
- 60 tablets - 4 mg1108-4-mg-13214
- 30 tablets - 8 mg1108-8-mg-13218